DOJ's Novel Cybersecurity FCA Case Is A Warning To Medtech
The U.S. Department of Justice's first-of-its-kind聽settlement聽with Illumina Inc. involved聽alleged cybersecurity deficiencies causing violations of the False Claims Act based on U.S. Food and Drug Administration quality standards....To view the full article, register now.
Already a subscriber? Click here to view full article